This page is part of the FHIR Specification (v4.4.0: R5 Preview #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2
Orders and Observations Work Group | Maturity Level: 0 | Informative | Use Context: Any |
This is a value set defined by the FHIR project.
Summary
Defining URL: | http://hl7.org/fhir/ValueSet/report-codes |
Version: | 4.4.0 |
Name: | LOINCDiagnosticReportCodes |
Title: | LOINC Diagnostic Report Codes |
Definition: | This value set includes LOINC codes that relate to Diagnostic Observations. |
Committee: | Orders and Observations Work Group |
OID: | 2.16.840.1.113883.4.642.3.233 (for OID based terminology systems) |
Copyright: | This content from LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use. |
Source Resource | XML / JSON |
This value set is used in the following places:
http://loinc.org
This expansion generated 03 May 2020
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
All codes from system http://loinc.org
Code | Display |
1-8 | Acyclovir [Susceptibility] |
10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer |
100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
10000-8 | R wave duration in lead AVR |
10001-6 | R wave duration in lead I |
10002-4 | R wave duration in lead II |
10003-2 | R wave duration in lead III |
10004-0 | R wave duration in lead V1 |
10005-7 | R wave duration in lead V2 |
10006-5 | R wave duration in lead V3 |
10007-3 | R wave duration in lead V4 |
10008-1 | R wave duration in lead V5 |
10009-9 | R wave duration in lead V6 |
1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor |
10010-7 | R' wave amplitude in lead AVF |
10011-5 | R' wave amplitude in lead AVL |
10012-3 | R' wave amplitude in lead AVR |
10013-1 | R' wave amplitude in lead I |
10014-9 | R' wave amplitude in lead II |
10015-6 | R' wave amplitude in lead III |
10016-4 | R' wave amplitude in lead V1 |
10017-2 | R' wave amplitude in lead V2 |
10018-0 | R' wave amplitude in lead V3 |
10019-8 | R' wave amplitude in lead V4 |
1002-5 | DBG Ab [Presence] in Serum or Plasma |
10020-6 | R' wave amplitude in lead V5 |
10021-4 | R' wave amplitude in lead V6 |
10022-2 | R' wave duration in lead AVF |
10023-0 | R' wave duration in lead AVL |
10024-8 | R' wave duration in lead AVR |
10025-5 | R' wave duration in lead I |
10026-3 | R' wave duration in lead II |
10027-1 | R' wave duration in lead III |
10028-9 | R' wave duration in lead V1 |
10029-7 | R' wave duration in lead V2 |
1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
10030-5 | R' wave duration in lead V3 |
10031-3 | R' wave duration in lead V4 |
10032-1 | R' wave duration in lead V5 |
10033-9 | R' wave duration in lead V6 |
10034-7 | S wave amplitude in lead AVF |
10035-4 | S wave amplitude in lead AVL |
10036-2 | S wave amplitude in lead AVR |
10037-0 | S wave amplitude in lead I |
10038-8 | S wave amplitude in lead II |
10039-6 | S wave amplitude in lead III |
1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
10040-4 | S wave amplitude in lead V1 |
10041-2 | S wave amplitude in lead V2 |
10042-0 | S wave amplitude in lead V3 |
10043-8 | S wave amplitude in lead V4 |
10044-6 | S wave amplitude in lead V5 |
10045-3 | S wave amplitude in lead V6 |
10046-1 | S wave duration in lead AVF |
10047-9 | S wave duration in lead AVL |
10048-7 | S wave duration in lead AVR |
10049-5 | S wave duration in lead I |
1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
10050-3 | S wave duration in lead II |
10051-1 | S wave duration in lead III |
10052-9 | S wave duration in lead V1 |
10053-7 | S wave duration in lead V2 |
10054-5 | S wave duration in lead V3 |
10055-2 | S wave duration in lead V4 |
10056-0 | S wave duration in lead V5 |
10057-8 | S wave duration in lead V6 |
10058-6 | S' wave amplitude in lead AVF |
10059-4 | S' wave amplitude in lead AVL |
1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
10060-2 | S' wave amplitude in lead AVR |
10061-0 | S' wave amplitude in lead I |
10062-8 | S' wave amplitude in lead II |
10063-6 | S' wave amplitude in lead III |
10064-4 | S' wave amplitude in lead V1 |
10065-1 | S' wave amplitude in lead V2 |
10066-9 | S' wave amplitude in lead V3 |
10067-7 | S' wave amplitude in lead V4 |
10068-5 | S' wave amplitude in lead V5 |
10069-3 | S' wave amplitude in lead V6 |
1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
10070-1 | S' wave duration in lead AVF |
10071-9 | S' wave duration in lead AVL |
10072-7 | S' wave duration in lead AVR |
10073-5 | S' wave duration in lead I |
10074-3 | S' wave duration in lead II |
10075-0 | S' wave duration in lead III |
10076-8 | S' wave duration in lead V1 |
10077-6 | S' wave duration in lead V2 |
10078-4 | S' wave duration in lead V3 |
10079-2 | S' wave duration in lead V4 |
1008-2 | Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma |
10080-0 | S' wave duration in lead V5 |
10081-8 | S' wave duration in lead V6 |
10082-6 | ST initial amplitude 6 ms in lead AVF |
10083-4 | ST initial amplitude 6 ms in lead AVL |
10084-2 | ST initial amplitude 6 ms in lead AVR |
10085-9 | ST initial amplitude 6 ms in lead I |
10086-7 | ST initial amplitude 6 ms in lead II |
10087-5 | ST initial amplitude 6 ms in lead III |
10088-3 | ST initial amplitude 6 ms in lead V1 |
10089-1 | ST initial amplitude 6 ms in lead V2 |
1009-0 | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
10090-9 | ST initial amplitude 6 ms in lead V3 |
10091-7 | ST initial amplitude 6 ms in lead V4 |
10092-5 | ST initial amplitude 6 ms in lead V5 |
10093-3 | ST initial amplitude 6 ms in lead V6 |
10094-1 | ST slope in lead AVF |
10095-8 | ST slope in lead AVL |
10096-6 | ST slope in lead AVR |
10097-4 | ST slope in lead I |
10098-2 | ST slope in lead II |
10099-0 | ST slope in lead III |
101-6 | Cefoperazone [Susceptibility] by Disk diffusion (KB) |
1010-8 | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit |
10100-6 | ST slope in lead V1 |
10101-4 | ST slope in lead V2 |
10102-2 | ST slope in lead V3 |
10103-0 | ST slope in lead V4 |
10104-8 | ST slope in lead V5 |
10105-5 | ST slope in lead V6 |
10106-3 | ST wave end displacement in lead AVF |
10107-1 | ST wave end displacement in lead AVL |
10108-9 | ST wave end displacement in lead AVR |
10109-7 | ST wave end displacement in lead I |
1011-6 | E sup(w) Ab [Presence] in Serum or Plasma from Donor |
10110-5 | ST wave end displacement in lead II |
10111-3 | ST wave end displacement in lead III |
10112-1 | ST wave end displacement in lead V1 |
10113-9 | ST wave end displacement in lead V2 |
10114-7 | ST wave end displacement in lead V3 |
10115-4 | ST wave end displacement in lead V4 |
10116-2 | ST wave end displacement in lead V5 |
10117-0 | ST wave end displacement in lead V6 |
10118-8 | ST wave mid displacement in lead AVF |
10119-6 | ST wave mid displacement in lead AVL |
1012-4 | E sup(w) Ab [Presence] in Serum or Plasma |
10120-4 | ST wave mid displacement in lead AVR |
10121-2 | ST wave mid displacement in lead I |
10122-0 | ST wave mid displacement in lead II |
10123-8 | ST wave mid displacement in lead III |
10124-6 | ST wave mid displacement in lead V1 |
10125-3 | ST wave mid displacement in lead V2 |
10126-1 | ST wave mid displacement in lead V3 |
10127-9 | ST wave mid displacement in lead V4 |
10128-7 | ST wave mid displacement in lead V5 |
10129-5 | ST wave mid displacement in lead V6 |
1013-2 | E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit |
10130-3 | T' wave amplitude in lead AVF |
10131-1 | T' wave amplitude in lead AVL |
10132-9 | T' wave amplitude in lead AVR |
10133-7 | T' wave amplitude in lead I |
10134-5 | T' wave amplitude in lead II |
10135-2 | T' wave amplitude in lead III |
10136-0 | T' wave amplitude in lead V1 |
10137-8 | T' wave amplitude in lead V2 |
10138-6 | T' wave amplitude in lead V3 |
10139-4 | T' wave amplitude in lead V4 |
1014-0 | E sup(w) Ag [Presence] on Red Blood Cells from Donor |
10140-2 | T' wave amplitude in lead V5 |
10141-0 | T' wave amplitude in lead V6 |
10142-8 | T wave amplitude in lead AVF |
10143-6 | T wave amplitude in lead AVL |
10144-4 | T wave amplitude in lead AVR |
10145-1 | T wave amplitude in lead I |
10146-9 | T wave amplitude in lead II |
10147-7 | T wave amplitude in lead III |
10148-5 | T wave amplitude in lead V1 |
10149-3 | T wave amplitude in lead V2 |
1015-7 | E sup(w) Ag [Presence] on Red Blood Cells |
10150-1 | T wave amplitude in lead V3 |
10151-9 | T wave amplitude in lead V4 |
10152-7 | T wave amplitude in lead V5 |
10153-5 | T wave amplitude in lead V6 |
10154-3 | Chief complaint Narrative - Reported |
10155-0 | History of allergies, reported |
10156-8 | History of Childhood diseases Narrative |
10157-6 | History of family member diseases Narrative |
10158-4 | History of Functional status Narrative |
10159-2 | History of Industrial exposure Narrative |
1016-5 | E Ab [Presence] in Serum or Plasma from Blood product unit |
10160-0 | History of Medication use Narrative |
10161-8 | History of Occupational exposure Narrative |
10162-6 | History of pregnancies Narrative |
10163-4 | History of pregnancies |
10164-2 | History of Present illness Narrative |
10165-9 | Deprecated History of psychiatric symptoms and diseases Narrative |
10166-7 | History of Social function Narrative |
10167-5 | History of Surgical procedures Narrative |
10168-3 | History of Cardiovascular system disorders Narrative |
10169-1 | History of Ear disorders Narrative |
1017-3 | E Ab [Presence] in Serum or Plasma from Donor |
10170-9 | History of Endocrine system disorders Narrative |
10171-7 | History of Eyes disorders Narrative |
10172-5 | History of Hematologic system disorders Narrative |
10173-3 | History of Musculoskeletal system disorders Narrative |
10174-1 | History of Nose disorders Narrative |
10175-8 | History of Oral cavity disorders Narrative |
10176-6 | History of Reproductive system disorders Narrative |
10177-4 | History of Respiratory system disorders Narrative |
10178-2 | History of Skin disorders Narrative |
10179-0 | History of Throat and Neck disorders Narrative |
1018-1 | E Ab [Presence] in Serum or Plasma |
10180-8 | History of Throat and Neck disorders |
10181-6 | History of Urinary tract disorders Narrative |
10182-4 | History of Travel Narrative |
10183-2 | Hospital discharge medications Narrative |
10184-0 | Hospital discharge physical findings Narrative |
10185-7 | Hospital discharge procedures Narrative |
10186-5 | Identifying information Narrative Observed |
10187-3 | Review of systems Narrative - Reported |
10188-1 | Review of systems overview Narrative - Reported |
10189-9 | Review of systems overview - Reported |
1019-9 | E Ag [Presence] on Red Blood Cells from Blood product unit |
10190-7 | Mental status Narrative |
10191-5 | Physical findings of Abdomen Narrative |
10192-3 | Physical findings of Back Narrative |
10193-1 | Physical findings of Breasts Narrative |
10194-9 | Physical findings of Neurologic deep tendon reflexes Narrative |
10195-6 | Physical findings of Ear Narrative |
10196-4 | Physical findings of Extremities Narrative |
10197-2 | Physical findings of Eye Narrative |
10198-0 | Physical findings of Genitourinary tract Narrative |
10199-8 | Physical findings of Head Narrative |
102-4 | Cefoperazone [Susceptibility] by Serum bactericidal titer |
1020-7 | E Ag [Presence] on Red Blood Cells from Donor |
10200-4 | Physical findings of Heart Narrative |
10201-2 | Physical findings of Mouth and Throat and Teeth Narrative |
10202-0 | Physical findings of Nervous system Narrative |
10203-8 | Physical findings of Nose Narrative |
10204-6 | Physical findings of Pelvis Narrative |
10205-3 | Physical findings of Rectum Narrative |
10206-1 | Physical findings of Skin Narrative |
10207-9 | Physical findings of Thorax and Lungs Narrative |
10208-7 | Physical findings of Vessels Narrative |
10209-5 | Physical findings of Neurologic balance and Coordination Narrative |
1021-5 | E Ag [Presence] on Red Blood Cells |
10210-3 | Physical findings of General status Narrative |
10211-1 | Physical findings of Sense of touch Narrative |
10212-9 | Physical findings of Strength Narrative |
10213-7 | Surgical operation note anesthesia Narrative |
10214-5 | Surgical operation note anesthesia duration |
10215-2 | Surgical operation note findings Narrative |
10216-0 | Surgical operation note fluids Narrative |
10217-8 | Surgical operation note indications [Interpretation] Narrative |
10218-6 | Surgical operation note postoperative diagnosis Narrative |
10219-4 | Surgical operation note preoperative diagnosis Narrative |
1022-3 | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
10220-2 | Surgical operation note prep time duration |
10221-0 | Surgical operation note specimens taken Narrative |
10222-8 | Surgical operation note surgical complications [Interpretation] Narrative |
10223-6 | Surgical operation note surgical procedure Narrative |
10224-4 | Hemodynamic method special circumstances |
10225-1 | Cardiac measurement device Institution inventory number |
10226-9 | Oxygen content in Intravascular space |
10227-7 | Cardiac measurement device Vendor model number |
10228-5 | Cardiac measurement device Vendor serial number |
10229-3 | Hemodynamic method Type of |
1023-1 | Fy sup(a) Ab [Presence] in Serum or Plasma from Donor |
10230-1 | Left ventricular Ejection fraction |
10231-9 | Right ventricular Ejection fraction |
10232-7 | Oxygen content in Aorta root |
10233-5 | Oxygen content in Left atrium |
10234-3 | Oxygen content in Right atrium |
10235-0 | Oxygen content in High right atrium |
10236-8 | Oxygen content in Low right atrium |
10237-6 | Oxygen content in Mid right atrium |
10238-4 | Oxygen content in Left ventricle |
10239-2 | Oxygen content in Right ventricular outflow tract |
1024-9 | Fy sup(a) Ab [Presence] in Serum or Plasma |
10240-0 | Oxygen content in Right ventricle |
10241-8 | Oxygen content in Coronary sinus |
10242-6 | Oxygen content in Ductus arteriosus |
10243-4 | Oxygen content in Inferior vena cava |
10244-2 | Oxygen content in Left pulmonary artery |
10245-9 | Oxygen content in Main pulmonary artery |
10246-7 | Oxygen content in Right pulmonary artery |
10247-5 | Oxygen content in Pulmonary wedge |
10248-3 | Oxygen content in Superior vena cava |
10249-1 | Heart rate device Institution inventory number |
1025-6 | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
10250-9 | Heart rate device Vendor model number |
10251-7 | Heart rate device Vendor serial number |
10252-5 | Biliary drain site |
10253-3 | Type of Biliary drain |
10254-1 | Type of Peritoneal drain |
10255-8 | Type of Subarachnoid drain |
10256-6 | Biliary drain Institution inventory number |
10257-4 | Chest tube Institution inventory number |
10258-2 | Enteral tube Institution inventory number |
10259-0 | Gastrostomy tube Institution inventory number |
1026-4 | Fy sup(a) Ag [Presence] on Red Blood Cells from Donor |
10260-8 | GI tube Institution inventory number |
10261-6 | Intravascular tube Institution inventory number |
10262-4 | IO tube Institution inventory number |
10263-2 | Nasogastric tube Institution inventory number |
10264-0 | Oral tube Institution inventory number |
10265-7 | Peritoneal drain Institution inventory number |
10266-5 | Peritoneal tube Institution inventory number |
10267-3 | Rate control device Institution inventory number |
10268-1 | Stool collection device Institution inventory number |
10269-9 | Subarachnoid drain Institution inventory number |
1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells |
10270-7 | Synovial drain Institution inventory number |
10271-5 | Tube or drain Institution inventory number |
10272-3 | Upper GI tube Institution inventory number |
10273-1 | Bladder irrigation tube Institution inventory number |
10274-9 | Urine tube Institution inventory number |
10275-6 | Wound drain device Institution inventory number |
10276-4 | Peritoneal drain site |
10277-2 | Stool collection site |
10278-0 | Subarachnoid drain site |
10279-8 | Biliary drain Vendor model number |
1028-0 | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
10280-6 | Chest tube Vendor model number |
10281-4 | Enteral tube Vendor model number |
10282-2 | Gastrostomy tube Vendor model number |
10283-0 | GI tube Vendor model number |
10284-8 | Intravascular tube Vendor model number |
10285-5 | IO tube Vendor model number |
10286-3 | Nasogastric tube Vendor model number |
10287-1 | Oral tube Vendor model number |
10288-9 | Peritoneal drain Vendor model number |
10289-7 | Peritoneal tube Vendor model number |
1029-8 | Fy sup(b) Ab [Presence] in Serum or Plasma from Donor |
10290-5 | Rate control device Vendor model number |
10291-3 | Stool collection device Vendor model number |
10292-1 | Subarachnoid drain Vendor model number |
10293-9 | Synovial drain Vendor model number |
10294-7 | Tube or drain Vendor model number |
10295-4 | Upper GI tube Vendor model number |
10296-2 | Bladder irrigation tube Vendor model number |
10297-0 | Urine tube Vendor model number |
10298-8 | Wound drain device Vendor model number |
10299-6 | Biliary drain Vendor serial number |
103-2 | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) |
1030-6 | Fy sup(b) Ab [Presence] in Serum or Plasma |
10300-2 | Chest tube Vendor serial number |
10301-0 | Enteral tube Vendor serial number |
10302-8 | Gastrostomy tube Vendor serial number |
10303-6 | GI tube Vendor serial number |
10304-4 | Intravascular tube Vendor serial number |
10305-1 | IO tube Vendor serial number |
10306-9 | Nasogastric tube Vendor serial number |
10307-7 | Oral tube Vendor serial number |
10308-5 | Peritoneal drain Vendor serial number |
10309-3 | Peritoneal tube Vendor serial number |
1031-4 | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
10310-1 | Rate control device Vendor serial number |
10311-9 | Stool collection device Vendor serial number |
10312-7 | Subarachnoid drain Vendor serial number |
10313-5 | Synovial drain Vendor serial number |
10314-3 | Tube or drain Vendor serial number |
10315-0 | Upper GI tube Vendor serial number |
10316-8 | Bladder irrigation tube Vendor serial number |
10317-6 | Urine tube Vendor serial number |
10318-4 | Wound drain device Vendor serial number |
10319-2 | Enema device Institution inventory number |
1032-2 | Fy sup(b) Ag [Presence] on Red Blood Cells from Donor |
10320-0 | Enema device Vendor model number |
10321-8 | Enema device Vendor serial number |
10322-6 | Potassium intake 24 hour |
10323-4 | Wound drain fluid [Appearance] Lower GI tract |
10324-2 | Breath rate device Institution inventory number |
10325-9 | Breath rate device Vendor model number |
10326-7 | Breath rate device Vendor serial number |
10327-5 | Eosinophils/100 leukocytes in Sputum by Manual count |
10328-3 | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
10329-1 | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells |
10330-9 | Monocytes/100 leukocytes in Body fluid by Manual count |
10331-7 | Rh [Type] in Blood |
10332-5 | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
10333-3 | Appearance of Cerebral spinal fluid |
10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
10335-8 | Color of Cerebral spinal fluid |
10336-6 | Gonadotropin peptide [Mass/volume] in Urine |
10337-4 | Procollagen type I [Mass/volume] in Serum |
10338-2 | Barbiturates [Mass/volume] in Serum or Plasma |
10339-0 | Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
1034-8 | Fetal cell screen [Interpretation] in Blood |
10340-8 | Molindone [Mass/volume] in Serum or Plasma |
10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma |
10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma |
10343-2 | Temazepam [Mass/volume] in Serum or Plasma |
10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma |
10345-7 | Trihexyphenidyl [Mass/volume] in Urine |
10346-5 | Hemoglobin A [Units/volume] in Blood by Electrophoresis |
10347-3 | Babesia microti identified in Blood by Light microscopy |
10348-1 | Bordetella parapertussis Ab [Presence] in Serum |
10349-9 | Brucella sp Ab [Units/volume] in Serum |
1035-5 | Fresh frozen plasma given [Volume] |
10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |
10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
10352-3 | Bacteria identified in Genital specimen by Aerobe culture |
10353-1 | Bacteria identified in Nose by Aerobe culture |
10354-9 | Bacteria identified in Urethra by Culture |
10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
10356-4 | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain |
10357-2 | Microscopic observation [Identifier] in Wound by Gram stain |
10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |
10359-8 | Asialoganglioside GM1 IgM Ab [Titer] in Serum |
1036-3 | G Ab [Presence] in Serum or Plasma from Blood product unit |
10360-6 | DNA single strand IgG Ab [Units/volume] in Serum |
10361-4 | DNA single strand IgM Ab [Units/volume] in Serum |
10362-2 | Endomysium IgA Ab [Presence] in Serum |
10363-0 | Barbiturates [Presence] in Unspecified specimen |
10364-8 | Cotinine [Mass/mass] in Hair |
10365-5 | Cotinine [Mass/volume] in Serum or Plasma |
10366-3 | Cotinine [Mass/volume] in Urine |
10367-1 | Ethanol [Mass/volume] in Gastric fluid |
10368-9 | Lead [Mass/volume] in Capillary blood |
10369-7 | Opiates [Mass/mass] in Hair |
1037-1 | G Ab [Presence] in Serum or Plasma from Donor |
10370-5 | Phencyclidine [Mass/mass] in Hair |
10371-3 | Bite cells [Presence] in Blood by Light microscopy |
10372-1 | Blister cells [Presence] in Blood by Light microscopy |
10373-9 | Fragments [Presence] in Blood by Light microscopy |
10374-7 | Helmet cells [Presence] in Blood by Light microscopy |
10375-4 | Irregularly contracted cells [Presence] in Blood by Light microscopy |
10376-2 | Oval macrocytes [Presence] in Blood by Light microscopy |
10377-0 | Pencil cells [Presence] in Blood by Light microscopy |
10378-8 | Polychromasia [Presence] in Blood by Light microscopy |
10379-6 | Erythrocytes.dual population [Presence] in Blood by Light microscopy |
1038-9 | G Ab [Presence] in Serum or Plasma |
10380-4 | Stomatocytes [Presence] in Blood by Light microscopy |
10381-2 | Target cells [Presence] in Blood by Light microscopy |
10382-0 | A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit |
10383-8 | A,B variant NOS Ag [Presence] on Red Blood Cells from Donor |
10384-6 | A,B variant NOS Ag [Presence] on Red Blood Cells |
10385-3 | Albumin concentration given |
10386-1 | Albumin given [Volume] |
10387-9 | Autologous erythrocytes given [Volume] |
10388-7 | Autologous whole blood given [Volume] |
10389-5 | Blood product.other [Type] |
1039-7 | G Ag [Presence] on Red Blood Cells from Blood product unit |
10390-3 | Blood product special preparation [Type] |
10391-1 | Cytomegalovirus immune globulin given [Volume] |
10392-9 | Cryoprecipitate given [Volume] |
10393-7 | Factor IX given [Type] |
10394-5 | Factor IX given [Volume] |
10395-2 | Factor VIII given [Type] |
10396-0 | Factor VIII given [Volume] |
10397-8 | Hepatitis B immune globulin given [Volume] |
10398-6 | I Ag [Presence] on Red Blood Cells from Blood product unit |
10399-4 | I Ag [Presence] on Red Blood Cells from Donor |
104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
1040-5 | G Ag [Presence] on Red Blood Cells from Donor |
10400-0 | I Ag [Presence] on Red Blood Cells |
10401-8 | Immune serum globulin given [Type] |
10402-6 | Immune serum globulin given [Volume] |
10403-4 | Inject immune serum globulin [Volume] |
10404-2 | Inject Rh immune globulin [Volume] |
10405-9 | Inject varicella zoster virus immune globulin [Volume] |
10406-7 | little i Ag [Presence] on Red Blood Cells from Blood product unit |
10407-5 | little i Ag [Presence] on Red Blood Cells from Donor |
10408-3 | little i Ag [Presence] on Red Blood Cells |
10409-1 | Pentaspan given [Volume] |
1041-3 | G Ag [Presence] on Red Blood Cells |
10410-9 | Plasma given [Type] |
10411-7 | Plasma given [Volume] |
10412-5 | Platelets given [Type] |
10413-3 | Rh immune globulin given [Volume] |
10414-1 | Transfuse albumin [Volume] |
10415-8 | Transfuse blood exchange transfusion [Volume] |
10416-6 | Transfuse blood product other [Volume] |
10417-4 | Transfuse cryoprecipitate [Volume] |
10418-2 | Transfuse factor IX [Volume] |
10419-0 | Transfuse factor VIII [Volume] |
1042-1 | H Ab [Presence] in Serum or Plasma from Blood product unit |
10420-8 | Transfuse immune serum globulin [Volume] |
10421-6 | Transfuse Pentaspan [Volume] |
10422-4 | Transfuse plasma [Volume] |
10423-2 | Transfuse platelets [Volume] |
10424-0 | Transfuse erythrocytes [Volume] |
10425-7 | Transfuse Rh immune globulin [Volume] |
10426-5 | Transfuse whole blood [Volume] |
10427-3 | Transfuse whole blood autologous [Volume] |
10428-1 | Varicella zoster virus immune globulin given [Volume] |
10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain |
1043-9 | H Ab [Presence] in Serum or Plasma from Donor |
10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain |
10431-5 | B-cell Ag [Presence] in Tissue by Immune stain |
10432-3 | CD30 Ag [Presence] in Tissue by Immune stain |
10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain |
10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain |
10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain |
10436-4 | CD15 Ag [Presence] in Tissue by Immune stain |
10437-2 | CD16 Ag [Presence] in Tissue by Immune stain |
10438-0 | CD20 Ag [Presence] in Tissue by Immune stain |
10439-8 | CD3 Ag [Presence] in Tissue by Immune stain |
1044-7 | H Ab [Presence] in Serum |
10440-6 | Deprecated CD30 Ag [Presence] in Tissue by Immune stain |
10441-4 | CD34 Ag [Presence] in Tissue by Immune stain |
10442-2 | CD56 Ag [Presence] in Tissue by Immune stain |
10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |
10444-8 | CD57 Ag [Presence] in Tissue by Immune stain |
10445-5 | CD11c Ag [Presence] in Tissue by Immune stain |
10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain |
10447-1 | M-5 Ag [Presence] in Tissue by Immune stain |
10448-9 | T-cell Ag [Presence] in Tissue by Immune stain |
10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
1045-4 | H NOS Ab [Presence] in Serum or Plasma from Blood product unit |
10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |
10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |
10452-1 | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
10453-9 | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO |
10454-7 | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
10455-4 | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO |
10456-2 | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting |
10457-0 | Actin Ag [Presence] in Tissue by Immune stain |
10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
1046-2 | H NOS Ab [Presence] in Serum or Plasma from Donor |
10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain |
10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain |
10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
10466-1 | Anion gap 3 in Serum or Plasma |
10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain |
10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
1047-0 | H NOS Ab [Presence] in Serum or Plasma |
10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain |
10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain |
10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain |
10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain |
10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain |
10476-0 | Desmin Ag [Presence] in Tissue by Immune stain |
10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
10479-4 | CD227 Ag [Presence] in Tissue by Immune stain |
1048-8 | H NOS Ag [Presence] on Red Blood Cells from Blood product unit |
10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain |
10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain |
10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain |
10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain |
10488-5 | IgA Ag [Presence] in Tissue by Immune stain |
10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
1049-6 | H NOS Ag [Presence] on Red Blood Cells from Donor |
10490-1 | IgE Ag [Presence] in Tissue by Immune stain |
10491-9 | IgG Ag [Presence] in Tissue by Immune stain |
10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
10493-5 | IgM Ag [Presence] in Tissue by Immune stain |
10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
10495-0 | Insulin Ag [Presence] in Tissue by Immune stain |
10496-8 | Kappa light chains Ag [Presence] in Tissue by Immune stain |
10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
10498-4 | Keratin Ag [Presence] in Tissue by Immune stain |
10499-2 | Lambda light chains Ag [Presence] in Tissue by Immune stain |
105-7 | Ceforanide [Susceptibility] by Disk diffusion (KB) |
1050-4 | H NOS Ag [Presence] on Red Blood Cells |
10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
10501-5 | Lutropin [Units/volume] in Serum or Plasma |
10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain |
10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain |
10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain |
10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain |
10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain |
10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain |
10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
1051-2 | Hemolytic disease of newborn screen [Interpretation] in Blood |
10510-6 | S-100 Ag Ag [Presence] in Tissue by Immune stain |
10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain |
10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain |
10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain |
10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain |
10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain |
10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain |
10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain |
10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain |
1052-0 | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit |
10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain |
10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |
10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain |
10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain |
10525-4 | Microscopic observation [Identifier] in Unspecified specimen by Cyto stain |
10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain |
10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain |
10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma |
10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma |
1053-8 | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor |
10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma |
10531-2 | Bretylium [Mass/volume] in Serum or Plasma |
10532-0 | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma |
10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |
10534-6 | Diazoxide [Mass/volume] in Serum or Plasma |
10535-3 | Digoxin [Mass/volume] in Serum or Plasma |
10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma |
10537-9 | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma |
10538-7 | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
10539-5 | Glipizide [Mass/volume] in Serum or Plasma |
1054-6 | Deprecated I (intermediate) subtype [Presence] in srum |
10540-3 | Glyburide [Mass/volume] in Serum or Plasma |
10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma |
10542-9 | Metharbital [Mass/volume] in Serum or Plasma |
10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
10544-5 | Normeperidine [Presence] in Serum or Plasma |
10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma |
10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma |
10547-8 | Primidone+Phenobarbital [Mass/volume] in Serum or Plasma |
10548-6 | Phenytoin Free/Phenytoin.total in Serum or Plasma |
10549-4 | Pirmenol [Mass/volume] in Serum or Plasma |
1055-3 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
10550-2 | Deprecated Temazepam [Mass/volume] in Serum or Plasma |
10551-0 | Triamterene [Mass/volume] in Serum or Plasma |
10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma |
10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |
10554-4 | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma |
10555-1 | Acrosin [Entitic Catalytic Activity] in Spermatozoa |
10556-9 | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma |
10557-7 | Adenosine triphosphate [Moles/volume] in Semen |
10558-5 | Albumin [Moles/volume] in Semen |
10559-3 | Deprecated Calcium [Molecules/volume] in Semen |
1056-1 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor |
10560-1 | Carcinoembryonic Ag [Units/volume] in Semen |
10561-9 | Carnitine [Moles/volume] in Semen |
10562-7 | Cells [#/volume] in Cervical mucus |
10563-5 | Cells other than spermatozoa [#/volume] in Semen |
10564-3 | Cervical mucus [Volume] |
10565-0 | Choriogonadotropin [Units/volume] in Semen |
10566-8 | Deprecated Choriogonadotropin [Molecules/volume] in Semen |
10567-6 | Citrate [Moles/volume] in Semen |
10568-4 | Clarity of Semen |
10569-2 | Color of Semen |
1057-9 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells |
10570-0 | Consistency of Cervical mucus |
10571-8 | Deprecated Consistency of Semen |
10572-6 | Deprecated Duration^post ejaculation |
10573-4 | Ferning [Type] in Cervical mucus |
10574-2 | Fructose [Moles/volume] in Semen |
10575-9 | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |
10576-7 | Germ cells.immature [#/volume] in Semen |
10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma |
10578-3 | Glycerophosphocholine [Moles/volume] in Seminal plasma |
10579-1 | Leukocytes [#/volume] in Semen |
1058-7 | I Ab [Presence] in Serum or Plasma from Blood product unit |
10580-9 | Liquefaction [Time] in Semen |
10581-7 | Deprecated Number of entities [#] in Spermatozoa |
10582-5 | pH of Cervical mucus |
10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen |
10584-1 | Deprecated Protein [Mass/volume] in Semen |
10585-8 | Round cells [#/volume] in Semen |
10586-6 | Deprecated Volume of Semen |
10587-4 | Sexual abstinence duration |
10588-2 | Spermatogonia [#/volume] in Semen |
10589-0 | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) |
1059-5 | I Ab [Presence] in Serum or Plasma from Donor |
10590-8 | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) |
10591-6 | Primary Spermatocytes [#/volume] in Semen |
10592-4 | Secondary Spermatocytes [#/volume] in Semen |
10593-2 | Spermatozoa Pyriform Head/100 spermatozoa in Semen |
10594-0 | Spermatozoa Tapering Head/100 spermatozoa in Semen |
10595-7 | Deprecated Spermatozoa [#/volume] in Semen |
10596-5 | Deprecated Spermatozoa Ab in cervical mucosa |
10597-3 | Deprecated Spermatozoa Ab in semen |
10598-1 | Deprecated Spermatozoa Ab in serum |
10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |
106-5 | Ceforanide [Susceptibility] by Serum bactericidal titer |
1060-3 | I Ab [Presence] in Serum or Plasma |
10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |
10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |
10602-1 | Spermatozoa Abnormal Head/100 spermatozoa in Semen |
10603-9 | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen |
10604-7 | Spermatozoa Abnormal Tail/100 spermatozoa in Semen |
10605-4 | Spermatozoa Agglutinated/100 spermatozoa in Semen |
10606-2 | Spermatozoa Amorphous Head/100 spermatozoa in Semen |
10607-0 | Spermatozoa Coiled Tail/100 spermatozoa in Semen |
10608-8 | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen |
10609-6 | Spermatozoa Duplicate Head/100 spermatozoa in Semen |
1061-1 | I NOS Ab [Presence] in Serum or Plasma from Blood product unit |
10610-4 | Spermatozoa Duplicate Tail/100 spermatozoa in Semen |
10611-2 | Spermatozoa Immotile/100 spermatozoa in Semen |
10612-0 | Spermatozoa Large Oval Head/100 spermatozoa in Semen |
10613-8 | Spermatozoa Viable/100 spermatozoa in Semen |
10614-6 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead |
10615-3 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction |
10616-1 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead |
10617-9 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction |
10618-7 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead |
10619-5 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction |
1062-9 | I NOS Ab [Presence] in Serum or Plasma from Donor |
10620-3 | Spermatozoa Nonprogressive/100 spermatozoa in Semen |
10621-1 | Spermatozoa Normal Head/100 spermatozoa in Semen |
10622-9 | Spermatozoa Normal/100 spermatozoa in Semen |
10623-7 | Spermatozoa Pin Head/100 spermatozoa in Semen |
10624-5 | Spermatozoa Rapid/100 spermatozoa in Semen |
10625-2 | Spermatozoa Round Head/100 spermatozoa in Semen |
10626-0 | Spermatozoa Slow/100 spermatozoa in Semen |
10627-8 | Spermatozoa Small Oval Head/100 spermatozoa in Semen |
10628-6 | Spermatozoa Tail Swelling/100 spermatozoa in Semen |
10629-4 | Spermatozoa Vacuolated Head/100 spermatozoa in Semen |
1063-7 | I NOS Ab [Presence] in Serum or Plasma |
10630-2 | Spinnbarkeit [Length] in Cervical mucus |
10631-0 | Testosterone [Moles/volume] in Semen |
10632-8 | Time until next menstrual period |
10633-6 | Zinc [Moles/volume] in Semen |
10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |
10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture |
10636-9 | Acanthamoeba sp identified in Eye by Wet preparation |
10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain |
10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Unspecified specimen by Organism specific culture |
10639-3 | Thermophilic Actinomycetes identified in Unspecified specimen by Organism specific culture |
1064-5 | I NOS Ag [Presence] on Red Blood Cells from Blood product unit |
10640-1 | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy |
10641-9 | Amoeba identified in Aspirate by Immune stain |
10642-7 | Amoeba identified in Aspirate by Wet preparation |
10643-5 | Amoeba identified in Stool by Organism specific culture |
10644-3 | Arthropod identified in Unspecified specimen |
10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |
10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy |
10647-6 | Babesia sp identified in Blood by Thick film |
10648-4 | Babesia sp identified in Blood by Thin film |
10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy |
1065-2 | I NOS Ag [Presence] on Red Blood Cells from Donor |
10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification |
10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |
10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |
10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
10654-2 | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) |
10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain |
10656-7 | Coccidia identified in Stool by Acid fast stain |
10657-5 | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence |
10658-3 | Cyanobacterium identified in Water by Light microscopy |
10659-1 | Cyclospora sp identified in Stool by Acid fast stain |
1066-0 | I NOS Ag [Presence] on Red Blood Cells |
10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain |
10661-7 | Dinoflagellate identified in Water by Light microscopy |
10662-5 | Filaria identified in Blood by Concentration |
10663-3 | Filaria identified in Blood by Thick film |
10664-1 | Filaria identified in Blood by Thin film |
10665-8 | Fungus colony count [#/volume] in Unspecified specimen by Environmental culture |
10666-6 | Fungus identified in Tissue by Fontana-Masson stain |
10667-4 | Fungus identified in Unspecified specimen by Animal inoculation |
10668-2 | Fungus identified in Unspecified specimen by Environmental culture |
10669-0 | Fungus identified in Unspecified specimen by Sticky tape for environmental fungus |
1067-8 | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture |
10671-6 | Helminth identified in Unspecified specimen |
10672-4 | Helminth+Arthropod identified in Unspecified specimen |
10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain |
10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain |
10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain |
10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain |
10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain |
10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain |
1068-6 | Jk sup(a) Ab [Presence] in Serum or Plasma from Donor |
10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy |
10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy |
10682-3 | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification |
10683-1 | Hydatid cyst identified in Aspirate by Immune stain |
10684-9 | Hydatid cyst identified in Liver by Wet preparation |
10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation |
10686-4 | Leishmania sp identified in Tissue by Giemsa stain |
10687-2 | Leishmania sp identified in Tissue by Organism specific culture |
10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation |
10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation |
1069-4 | Jk sup(a) Ab [Presence] in Serum or Plasma |
10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified |
10691-4 | Mushroom.toxic identified by Inspection |
10692-2 | Mushroom.toxic identified in Food by Light microscopy |
10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy |
10694-8 | Naegleria sp identified in Tissue by Organism specific culture |
10695-5 | Naegleria sp identified in Tissue by Wet preparation |
10696-3 | Norovirus [Identifier] in Stool by Electron microscopy |
10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) |
10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) |
10699-7 | Onchocerca sp identified in Tissue by Wet preparation |
107-3 | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) |
1070-2 | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy |
10701-1 | Ova and parasites identified in Stool by Concentration |
10702-9 | Ova and parasites identified in Stool by Immune stain |
10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain |
10704-5 | Ova and parasites identified in Stool by Light microscopy |
10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain |
10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy |
10707-8 | Toxic Plant identified in Plant specimen by Inspection |
10708-6 | Toxic Plant identified in Vomitus by Light microscopy |
10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence |
1071-0 | Jk sup(a) Ag [Presence] on Red Blood Cells from Donor |
10710-2 | Plasmodium sp identified in Blood by Thin film |
10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence |
10712-8 | Pneumocystis sp identified in Lung tissue |
10713-6 | Prototheca identified in Unspecified specimen by Culture |
10714-4 | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy |
10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy |
10716-9 | Schistosoma sp identified in Unspecified specimen by Organism specific culture |
10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |
10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot |
1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells |
10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) |
10721-9 | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) |
10722-7 | Torovirus [Identifier] in Stool by Electron microscopy |
10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay |
10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay |
10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification |
10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain |
10727-6 | Toxoplasma gondii identified in Tissue |
10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture |
10729-2 | Trypanosoma sp identified in Blood by Light microscopy |
1073-6 | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
10730-0 | Trypanosoma sp identified in Blood by Organism specific culture |
10731-8 | Trypanosoma sp identified in Blood by Thick film |
10732-6 | Trypanosoma sp identified in Blood by Thin film |
10733-4 | Trypanosoma sp identified in Blood by Wet preparation |
10734-2 | Varicella zoster virus identified in Skin by Electron microscopy |
10735-9 | Viral sequencing [Identifier] in Serum by Sequencing |
10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy |
10737-5 | Virus identified in Stool by Electron microscopy |
10738-3 | Virus identified in Tissue by Electron microscopy |
10739-1 | Virus identified in Unspecified specimen by Electron microscopy |
1074-4 | Jk sup(b) Ab [Presence] in Serum or Plasma from Donor |
10740-9 | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain |
10741-7 | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain |
10742-5 | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified |
10743-3 | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain |
10744-1 | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain |
10745-8 | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain |
10746-6 | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain |
10747-4 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain |
10748-2 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain |
10749-0 | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain |
1075-1 | Jk sup(b) Ab [Presence] in Serum or Plasma |
10750-8 | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson |
10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |
10752-4 | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain |
10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |
10754-0 | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain |
10755-7 | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott |
10756-5 | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain |
10757-3 | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald |
10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain |
10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain |
1076-9 | Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain |
10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain |
10762-3 | Microscopic observation [Identifier] in Blood by Hemosiderin stain |
10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain |
10764-9 | Microscopic observation [Identifier] in Sputum by Silver stain |
10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain |
10766-4 | Microscopic observation [Identifier] in Tissue by Alcian blue stain |
10767-2 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated |
10768-0 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff |
10769-8 | Microscopic observation [Identifier] in Tissue by Alizarin red S stain |
1077-7 | Jk sup(b) Ag [Presence] on Red Blood Cells from Donor |
10770-6 | Microscopic observation [Identifier] in Tissue by Argentaffin stain |
10771-4 | Deprecated Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain |
10772-2 | Microscopic observation [Identifier] in Tissue by Azure-eosin stain |
10773-0 | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain |
10774-8 | Microscopic observation [Identifier] in Tissue by Bielschowsky stain |
10775-5 | Microscopic observation [Identifier] in Tissue by Bleach stain |
10776-3 | Microscopic observation [Identifier] in Tissue by Bodian stain |
10777-1 | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain |
10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain |
10779-7 | Microscopic observation [Identifier] in Tissue by Carmine stain.Best |
1078-5 | Jk sup(b) Ag [Presence] on Red Blood Cells |
10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain |
10781-3 | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain |
10782-1 | Microscopic observation [Identifier] in Tissue by Congo red stain |
10783-9 | Microscopic observation [Identifier] in Tissue by Crystal violet stain |
10784-7 | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific |
10785-4 | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain |
10786-2 | Deprecated Microscopic observation [Identifier] in Tissue by Giemsa stain.3 micron |
10787-0 | Microscopic observation [Identifier] in Tissue by Gridley stain |
10788-8 | Microscopic observation [Identifier] in Tissue by Hansel stain |
10789-6 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain |
1079-3 | Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
10790-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain |
10791-2 | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain |
10792-0 | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones |
10793-8 | Microscopic observation [Identifier] in Tissue by Methyl green stain |
10794-6 | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain |
10795-3 | Microscopic observation [Identifier] in Tissue by Methyl violet stain |
10796-1 | Microscopic observation [Identifier] in Tissue by Mucicarmine stain |
10797-9 | Microscopic observation [Identifier] in Tissue by Neutral red stain |
10798-7 | Microscopic observation [Identifier] in Tissue by Oil red O stain |
10799-5 | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat |
108-1 | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
1080-1 | Js sup(a) Ab [Presence] in Serum or Plasma from Donor |
10800-1 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion |
10801-9 | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain |
10802-7 | Microscopic observation [Identifier] in Tissue by Prussian blue stain |
10803-5 | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain |
10804-3 | Microscopic observation [Identifier] in Tissue by Reticulin stain |
10805-0 | Microscopic observation [Identifier] in Tissue by Safranin stain |
10806-8 | Microscopic observation [Identifier] in Tissue by Schmorl stain |
10807-6 | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain |
10808-4 | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle |
10809-2 | Microscopic observation [Identifier] in Tissue by Silver nitrate stain |
1081-9 | Js sup(a) Ab [Presence] in Serum or Plasma |
10810-0 | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson |
10811-8 | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius |
10812-6 | Microscopic observation [Identifier] in Tissue by Steiner stain |
10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain |
10814-2 | Microscopic observation [Identifier] in Tissue by Supravital stain |
10815-9 | Microscopic observation [Identifier] in Tissue by Tetrachrome stain |
10816-7 | Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain |
10817-5 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley |
10818-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified |
10819-1 | Microscopic observation [Identifier] in Tissue by Wade stain |
1082-7 | Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
10820-9 | Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain |
10821-7 | Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain |
10822-5 | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer |
10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale |
10824-1 | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain |
10825-8 | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain |
10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain |
10827-4 | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain |
10828-2 | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain |
10829-0 | Silicon [Mass/volume] in Serum or Plasma |
1083-5 | Js sup(a) Ag [Presence] on Red Blood Cells from Donor |
10830-8 | Deprecated Surgical operation note complications |
10831-6 | Surgical operation note complications [Interpretation] |
10832-4 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 50 g lactose PO |
10833-2 | Insulin [Mass/volume] in Serum or Plasma --7 hours post 75 g glucose PO |
10834-0 | Globulin [Mass/volume] in Serum by calculation |
10835-7 | Lipoprotein a [Mass/volume] in Serum or Plasma |
10836-5 | Niacin [Mass/volume] in Blood |
10837-3 | Organic acids [Presence] in Serum or Plasma |
10838-1 | Phosphoserine [Mass/volume] in Serum or Plasma |
10839-9 | Troponin I.cardiac [Mass/volume] in Serum or Plasma |
1084-3 | Js sup(a) Ag [Presence] on Red Blood Cells |
10840-7 | Atropine [Mass/volume] in Urine |
10841-5 | Methazolamide [Mass/volume] in Serum or Plasma |
10842-3 | Deprecated HLA-DQ1 [Presence] |
10843-1 | Deprecated HLA-DQ2 [Presence] |
10844-9 | Deprecated HLA-DQ3 [Presence] |
10845-6 | Deprecated HLA-DQ4 [Presence] |
10846-4 | Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification |
10847-2 | Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification |
10848-0 | Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence |
10849-8 | Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence |
1085-0 | Js sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
10850-6 | Cyclospora cayetanensis [Presence] in Unspecified specimen |
10851-4 | Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture |
10852-2 | Deprecated Fungus identified in Blood by Culture |
10853-0 | Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified |
10854-8 | Deprecated Midrofilaria identified in Blood by Concentration |
10855-5 | Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy |
10856-3 | Microscopic observation [Identifier] in Genital mucus by Gram stain |
10857-1 | Microsporidia identified in Unspecified specimen by Light microscopy |
10858-9 | Teichoate Ab [Presence] in Serum |
10859-7 | Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain |
1086-8 | Js sup(b) Ab [Presence] in Serum or Plasma from Donor |
10860-5 | Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture |
10861-3 | Progesterone receptor [Mass/mass] in Tissue |
10862-1 | Basement membrane Ab [Titer] in Serum |
10863-9 | Endomysium IgA Ab [Titer] in Serum |
10864-7 | Immune complex [Units/volume] in Serum or Plasma by Raji cell assay |
10865-4 | Intercellular substance Ab [Presence] in Serum |
10866-2 | Sulfatide IgG Ab [Titer] in Serum |
10867-0 | Sulfatide IgM Ab [Titer] in Serum |
10868-8 | Bacitracin [Susceptibility] by Disk diffusion (KB) |
10869-6 | Xylose [Mass/volume] in Blood --3 hours post 25 g xylose PO |
1087-6 | Js sup(b) Ab [Presence] in Serum or Plasma |
10870-4 | Xylose [Mass/volume] in Blood --4 hours post 25 g xylose PO |
10871-2 | Xylose [Mass/volume] in Blood --5 hours post 25 g xylose PO |
10872-0 | Xylose [Mass/volume] in Blood --baseline |
10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine |
10874-6 | Bombesin [Mass/volume] in Plasma |
10875-3 | Carnitine esters [Mass/volume] in Urine |
10876-1 | Carnitine esters [Mass/volume] in Serum or Plasma |
10877-9 | Carnitine free (C0) [Mass/volume] in Urine |
10878-7 | Iodine.protein bound [Mass/volume] in Serum or Plasma |
10879-5 | Isovalerylglycine [Mass/volume] in Urine |
1088-4 | Js sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
10880-3 | Magnesium [Mass/mass] in Stool |
10881-1 | Pentacarboxylporphyrins [Mass/volume] in Red Blood Cells |
10882-9 | Pentacarboxylporphyrins [Mass/volume] in Serum or Plasma |
10883-7 | Phenolphthalein [Mass/mass] in Stool |
10884-5 | Phosphate [Mass/mass] in Stool |
10885-2 | Porphyrins [Mass/time] in 24 hour Urine |
10886-0 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
10887-8 | Pyridinoline [Mass/time] in 24 hour Urine |
10888-6 | Lipase [Enzymatic activity/volume] in Urine |
10889-4 | Bisacodyl [Mass/mass] in Stool |
1089-2 | Js sup(b) Ag [Presence] on Red Blood Cells from Donor |
10890-2 | Deprecated Normethsuximide [Mass/volume] in Serum or Plasma |
10891-0 | Oxyphenisatin [Mass/mass] in Stool |
10892-8 | Pentoxifylline [Mass/volume] in Serum or Plasma |
10893-6 | Trenbolone [Mass/volume] in Urine |
10894-4 | Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID) |
10895-1 | Clostridium difficile toxin B [Presence] in Stool |
10896-9 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
10897-7 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
10898-5 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |